Searched for
ELI LILLY AND CO
Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...- Eli Lilly's Alzheimer's drug donanemab approved in India, but neurologists flag cost, access barriersA new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...
- CEOs are getting ruthless about worker performanceCorporate leaders are increasingly prioritizing results over employee comfort, with CEOs like Unilever's Fernando Fernandez demanding "volu...
- Google’s Isomorphic Labs to raise over $2 billion in new fundingAlphabet's AI drug discovery firm, Isomorphic Labs, is reportedly close to securing over $2 billion in new funding, led by Thrive Capital. ...
- Novo rebrands diabetes pill as Ozempic to tap blockbuster nameNovo Nordisk is relaunching a diabetes tablet as Ozempic in the United States. This move aims to boost sales by using the strong brand reco...
- Trump unveils deal with Regeneron to lower drug prices as part of most-favored-nation initiativeRegeneron will reduce prices for its drugs on Medicaid. A cholesterol drug, Praluent, will be available for USD 225 on Trump's discounted d...
- Novo Nordisk’s weight-loss drug patent loss sparks a ‘gold rush’ for generic drugmakersIndia's weight-loss drug market is seeing a major shift. Generic versions of Novo Nordisk's semaglutide are now available at lower prices. ...
- Eli Lilly impersonator reveals identity after drug company's stocks fall with his fake tweetThe person whose tweet about ‘Insulin is free’ from a parody account of Eli Lilly goes public by sharing a video. The tweet caused the stoc...
- Lilly says antibody drug cuts COVID-19 hospitalization, may seek emergency use nodOf the total 302 patients treated with the Lilly drug, five or 1.7%, had to be hospitalized or required an emergency room visit. That compa...
- Novartis completes transcation to sell animal health business to Elanco IndiaNovartis India has completed the transaction to sell its animal health business to Elanco India, an affiliate of Eli Lilly.
- Elanco gets FIPB nod to acquire Novartis' animal health businessElanco India is now awaiting approval from the Competition Commission of India after which both the companies will close the transaction, i...
- Eli Lilly aims to be among top 20 pharma companies in India by 2020The company lays maximum emphasis on its diabetes portfolio and would be introducing new products to cater to over 60 million patients in t...
- Strides Arcolab inks pact with Eli Lilly for cancer drugsAgila Specialties will manufacture the cancer medicines, and Lilly will register and market them in geographies across the emerging markets...
- HCL Tech in pact with Eli Lilly for developing technologiesHCL and Eli Lilly entered into a partnership for developing technologies & improving operational efficiencies to enhance latter's global co...
- Eli Lilly insulin brand paves way for hike in imported drug pricesThe NPPA will have to increase MRP of US firm Eli Lilly’s insulin brand, paving the way for price increases of other imported medicines who...
- Eli Lilly agrees to buy ImClone for over $6bnThe drugmaker Eli Lilly & Co says it has agreed to buy biotechnology company ImClone Systems Inc. for more than $6 billion in a deal that w...
- Sun Pharma gets approval for Gemzar injectionSun Pharmaceutical Industries has received approval from USFDA for the abbreviated new drug application for its generic version of Eli Lill...
- Eli Lilly plans to expand India opsUS drug major Eli Lilly & Co has decided to expand its business in India beyond R&D initiatives.
- US firm drags Sun Pharma to court on StratteraUS drug giant Eli Lilly & Co has filed a patent infringement suit against Sun Pharmaceutical Industries to prevent the latter from selling ...
- Eli Lilly to invest $50m in TB eradication allianceEli Lilly and Co will invest an additional $50 million in Lilly Multi-Drug Resistant Tuberculosis (MDR-TB) Partnership, a global TB eradica...
Load More
